PDGFRB and neoplasm: Furthermore, vemurafenib therapy significantly (p=0.007) reduced 2-fold vascular density (Figure 2E) and tumor microenvironment-associated PDGFRB protein levels in the BRAFWT/V600E-KTC1 tumor vs. vehicle-treated mice (Figure 2I, and Supplementary information).